MedPath

Artificial Root-End Barriers

Completed
Conditions
Dental Cements
Tooth Abnormalities
Registration Number
NCT00595842
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Brief Summary

This study retrospectively looks to determine the clinical success of ProRoot MTA used as an artificial apical barrier in teeth with immature apices.

Detailed Description

The normal development and maturation of a root depends on a vital, healthy pulp. If the pulp becomes necrotic in a tooth with an immature apex, endodontic treatment can be performed using an artificial barrier technique. Mineral trioxide aggregate (MTA) has become the material of choice to accomplish this procedure, however, few studies have evaluated its clinical success. The purpose of this retrospective study was to determine the clinical success of ProRoot MTA used as an artificial apical barrier. Twenty patients were included in this study. After approximately one week of Ca(OH)2 treatment, each patient had MTA placed as an apical barrier in a tooth with a single canal and open apex followed by placement of a final restoration. Patients were recalled and evaluated for clinical signs and symptoms and osseous healing. Immediate post-treatment and recall radiographs were evaluated by two endodontists calibrated for use of the Periapical Index (PAI).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • a tooth with a single canal and presence of an open apex by radiograph
  • Ca(OH)2 treatment for at least one week prior to obturation
  • use of MTA to produce an artificial apical barrier
  • placement of a final restoration
  • radiographs codumenting pretreatment and immedicate post-treatment conditionof the tooth
  • patients ages 5-40 years old
Exclusion Criteria
  • patients younger than 5 and greater than 40 years old
  • patients unable to be contacted for recall during the study
  • patients with a medical condition whose health would be jeopardized by participation in the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Texas Health Science Center

🇺🇸

San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath